iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Rhea-AI Summary
iRhythm Holdings (NASDAQ: IRTC) will release fourth quarter and full year 2025 financial results after market close on February 19, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with a live and archived webcast available on the company’s investor site.
Positive
- None.
Negative
- None.
News Market Reaction – IRTC
In the Feb 6 session, IRTC declined 0.19%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Prelim results & outlook | Positive | -5.8% | Preliminary Q4 2025 revenue beat guidance and raised 2026 outlook. |
| Dec 29 | Conference presentation | Neutral | -0.0% | Announcement of J.P. Morgan Healthcare Conference presentation schedule. |
| Nov 21 | Clinical data APHRS | Positive | +4.8% | Large APHRS 2025 analysis supporting Zio LTCM performance across populations. |
| Nov 11 | Real‑world study data | Positive | +0.0% | Publication and AHA data highlighting benefits of longer-term Zio monitoring. |
| Nov 04 | Investor conferences | Neutral | -0.3% | Participation in multiple upcoming investor conferences with webcast access. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive fundamental or clinical news has sometimes seen muted or negative next-day reactions, while neutral event announcements have generally coincided with modest stock moves.
Recent news shows a mix of financial and clinical milestones. On Jan 12, 2026 (news_id 955785), iRhythm shared preliminary Q4 2025 highlights and >guidance above prior levels, yet the stock moved -5.82% the next day, indicating a divergence from positive fundamentals. Earlier in November 2025, large real‑world and regional Zio monitoring datasets (news_ids 939648, 933832) aligned with flat to positive reactions. Today’s earnings-date announcement slots into this cadence of scheduled investor updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
mediarelations@irhythmtech.com
